Ventas Inc
NYSE:VTR
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
56.9
81
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
VTR
stock under the Base Case scenario is
54.2
USD.
Compared to the current market price of 77.86 USD,
Ventas Inc
is
Overvalued by 30%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Ventas Inc.
| US |
|
Welltower Inc
NYSE:WELL
|
|
| US |
|
Omega Healthcare Investors Inc
NYSE:OHI
|
|
| US |
H
|
Healthpeak Properties Inc
F:HC5
|
|
| US |
|
Physicians Realty Trust
NYSE:DOC
|
|
| US |
C
|
CareTrust REIT Inc
NYSE:CTRE
|
|
| US |
H
|
Healthcare Trust Of America Inc
F:HT01
|
|
| US |
|
Healthcare Realty Trust Inc
NYSE:HR
|
|
| US |
|
Sabra Health Care REIT Inc
NASDAQ:SBRA
|
|
| US |
|
National Health Investors Inc
NYSE:NHI
|
|
| BE |
|
Aedifica NV
XBRU:AED
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Ventas’ senior housing segment faces oversupply in certain markets and rising labor costs, which could pressure operator margins and reduce Ventas’ ability to raise rents or maintain occupancy levels, ultimately impacting NOI growth.
The company’s high leverage in a rising interest rate environment may dampen its ability to refinance existing debt affordably, squeeze cash flow, and limit Ventas’ capacity to pursue accretive acquisitions.
Ventas has significant operator concentration, especially with large tenants in senior living; if a major operator were to experience financial distress, it could disrupt rental income and cause concerns about the stability of Ventas’ cash flow.
As baby boomers enter retirement, the aging demographics signal steady demand growth for senior housing and healthcare real estate, positioning Ventas to capture higher occupancy and rental rate increases over the long term.
Ventas’ diversified portfolio, which includes life science and academic medical properties, benefits from resilient demand and strong credit tenants, partially insulating the company’s fundamentals from downturns in the broader REIT sector.
With a manageable debt maturity profile and historically strong access to capital markets, Ventas is well equipped to fund acquisitions and redevelop its properties, preserving growth potential even amid short-term macroeconomic headwinds.
Revenue & Expenses Breakdown
Ventas Inc
Balance Sheet Decomposition
Ventas Inc
| Current Assets | 281.1m |
| Cash & Short-Term Investments | 188.6m |
| Receivables | 92.5m |
| Non-Current Assets | 26.6B |
| Long-Term Investments | 751.2m |
| PP&E | 23.9B |
| Intangibles | 1.1B |
| Other Non-Current Assets | 912.1m |
| Current Liabilities | 1.7B |
| Accounts Payable | 1.2B |
| Accrued Liabilities | 329.4m |
| Other Current Liabilities | 107.3m |
| Non-Current Liabilities | 12.6B |
| Long-Term Debt | 12.5B |
| Other Non-Current Liabilities | 86.5m |
Free Cash Flow Analysis
Ventas Inc
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Ventas Inc
|
Revenue
|
5.6B
USD
|
|
Cost of Revenue
|
-3.2B
USD
|
|
Gross Profit
|
2.3B
USD
|
|
Operating Expenses
|
-1.4B
USD
|
|
Operating Income
|
922.1m
USD
|
|
Other Expenses
|
-684.1m
USD
|
|
Net Income
|
238m
USD
|
VTR Profitability Score
Profitability Due Diligence
Ventas Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.
Score
Ventas Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.
VTR Solvency Score
Solvency Due Diligence
Ventas Inc's solvency score is 23/100. The higher the solvency score, the more solvent the company is.
Score
Ventas Inc's solvency score is 23/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
VTR Price Targets Summary
Ventas Inc
According to Wall Street analysts, the average 1-year price target for
VTR
is 85.52 USD
with a low forecast of 75.75 USD and a high forecast of 95.55 USD.
Dividends
Current shareholder yield for
VTR is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
VTR
stock under the Base Case scenario is
54.2
USD.
Compared to the current market price of 77.86 USD,
Ventas Inc
is
Overvalued by 30%.